Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

More articles from Commentary

  • You have access
    Genetic discrimination arising from cancer risk assessments: A societal dilemma
    Maurie Markman, MD
    Cleveland Clinic Journal of Medicine January 2004, 71 (1) 12;

    The right to privacy of one’s most intimate biological secrets must be affirmed.

  • You have access
    The needs of science vs the needs of patients: Ethical concernsin cancer clinical trials
    Maurie Markman, MD
    Cleveland Clinic Journal of Medicine December 2003, 70 (12) 1008-1015;

    Patients in cancer trials are not data points; they are vulnerable people who often view a clinical trial as their last hope.

  • You have access
    Are we winning or losing the war on cancer?
    Maurie Markman, MD
    Cleveland Clinic Journal of Medicine July 2003, 70 (7) 632-633;

    The news from the cancer front is good and bad.

  • You have access
    Privacy protection for your patients: Understanding the federal requirements
    Daniel E. Nickelson, John E. Steiner, ESQ and Neil Mehta, MD
    Cleveland Clinic Journal of Medicine March 2003, 70 (3) 182-190;

    On April 14, 2003, almost every medical provider in this country must implement new federal privacy rules. Here’s how.

  • You have access
    GUSTO V: Should it affect clinical practice?
    James L. Orford, MBCHB, MPH and Peter B. Berger, MD
    Cleveland Clinic Journal of Medicine July 2002, 69 (7) 520-522;

    The results of GUSTO V were equivocal and should not lead physicians to change how they treat myocardial infarction.

  • You have access
    The dangers of self-monitored dieting: What are our patients really doing?
    Cindy L. Moore, MS, RD, LD
    Cleveland Clinic Journal of Medicine September 2001, 68 (9) 777-781;

    Patient-monitored diets often leave questions of adherence and safety unanswered.

  • You have access
    C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biologic aging
    Irving Kushner, MD
    Cleveland Clinic Journal of Medicine June 2001, 68 (6) 535-537;

    CRP elevations are a sensitive test for inflammation, hut are not specific.

  • You have access
    In cholesterol lowering, moderation kills
    Caldwell B. Esselstyn, MD
    Cleveland Clinic Journal of Medicine August 2000, 67 (8) 560-564;

    The author’s experience indicates that a low-fat, plant-based diet can lower cholesterol to less than 150 mg/dL and reverse coronary artery disease.

  • You have access
    Of rice, grain, and zeal: Lessons from Drs. Kempner and Esselstyn
    Norman B. Ratliff, MD
    Cleveland Clinic Journal of Medicine August 2000, 67 (8) 565-566;

    Two physicians who successfully motivated their patients to make lifestyle changes were true believers.

  • You have access
    Fibrinolytic therapy in the elderly: Making sense of troubling new findings
    Gary S. Francis, MD
    Cleveland Clinic Journal of Medicine August 2000, 67 (8) 574-576;

    Do patients older than 75 years with acute MI benefit from fibrinolytic therapy? For now, we have to live with uncertainty.

Pages

  • Previous
  • Next
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire